Document is current

Article History

Received: 14 January 2025

Accepted: 18 December 2025

First Online: 24 January 2026

Change Date: 6 March 2026

Change Type: Update

Change Details: Following original publication, affiliation 2 has been updated to correct “Institución educativa Visión de las Americas” to “Institución Universitaria Visión de las Américas”.

Declarations

:

: This study was approved by the Bioethics Committee of the Universidad Tecnológica de Pereira under the “no risk” research category (approval code: 76-241022. Date: October 22, 2021). The ethical principles established by the Declaration of Helsinki were followed. Risk-free investigations that collect data from clinical records do not require informed consent according to Resolution 8430 of 1993 of the Colombian Ministry of Health. According to regulations in Colombia, observational studies conducted on secondary databases do not require informed consent.

: All authors agree to the publication of the manuscript in its final version.

: Reyes JM, Castaño-Gamboa N, Rubio A and Mesa A are employees of Pfizer. Pfizer did not participate in the management or data analysis of the study information. Gaviria-Mendoza A, Machado-Duque M, Valladales-Restrepo L, and Machado-Alba J have developed studies funded by GSK, Pfizer, Biotoscana, Sanofi, Sanofi-Pasteur, Abbot, Tecnoquímicas, Bayer, and Novartis. Gómez D has not conflict of interest.